Translate
Subscribe to Blog via Email
Ronny Allan
Welcome to my Neuroendocrine Cancer Glossary of Terms list providing a source of meanings for acronyms and medical terms, all sourced from top Neuroendocrine Cancer and general cancer sites.
How to use this list:
1. If your term begins with an A, click on A to find all terms beginning with A. Select your term from the list.
2. For numerical terms, please click on the hashtag (#) symbol in the A-to-Z strip.
3. The term definition including acronym or abbreviation will be given in full along with any of my published articles containing that term as long as I have tagged it on my website to display in the list.
Please note I’m constantly working on the repository to clean up all definitions, adding and removing links where necessary, and ensuring all definitions are linked to at least one article. Where a definition is not yet linked to an article, the definition will still be listed, and you will see a message saying “nothing found” and offering you a search of my entire website.
Thanks for supporting this repository which was a “lock-down” project.
Ronny
Can’t see the definition you’re looking for? Or is there a broken link? Have a problem with the meaning given? Please contact me using the form below to request an add or update.
Please note I’m constantly working on the repository to clean up all definitions, adding and removing links where necessary, and ensuring all definitions are linked to at least one article. Where a definition is not yet linked to an article, the definition will still be listed, and you will see a message saying “nothing found” and offering you a search of my entire website.
Thanks for supporting this repository which was a “lock-down” project.
Ronny
A
- Abdomen
- Ablation
- Abscess
- ACE inhibitor
- Achlorhydria
- Acid reflux
- Acromegaly
- ACTHoma
- Actin
- Acute
- Ac-225
- Addison's disease
- Adenocarcinoma
- Adenoma
- Adhesions
- Adjunctive therapy
- Adjuvant surgery
- Adjuvant therapy
- Adrenaline
- Adrenal cortex
- Adrenal glands
- Adrenal insufficiency
- Adrenal medulla
- Adrenocortical Carcinoma (ACC)
- Adrenocorticotropic Hormone (ACTH)
- Advanced neuroendocrine cancer
- AdVince
- Afinitor
- Aggressive
- Agonist
- Albumin
- Alcohol
- Alcohol flushing reaction
- ALDH2
- Aldosterone
- Allergies
- Alopecia
- alt
- Alternative medicine
- Alternative therapies
- American Society of Clinical Oncology (ASCO)
- Amines
- Amino acids
- Amoxicillin
- Ampulla
- Ampulla of Vater
- Amylase
- Analogue (US Analog)
- Anaphylactic shock
- Anaplastic
- Anastomosis
- Androgrens
- Anemia
- Anesthesia
- Aneurysm
- Angiogenesis
- Angiogenesis inhibitor
- Angiogram
- Angioma
- Anorexia
- Antagonist
- Anterior
- Antiacids
- Antibiotics
- Antibody
- Anticoagulant
- Antidepressant
- Antiemetic agent
- Antigen
- Antihistamines
- Antineoplastic therapy
- Antioxident
- Anti-angiogenic therapy
- Anxiety
- AOH1966
- Aorta
- Apoptosis
- Appendectomy
- Appendiceal NET
- Appendix
- Apudoma
- Aretha Franklin
- Arrhymia
- Arterial embolization
- Ascending colon
- Ascites
- Aspiration
- Assay
- Asthma
- ASTX727
- Ataxia
- Atezolizumab (Tecentriq)
- Atopic dermatitis
- Atrophic gastritis
- ATRX
- Atypical
- Atypical carcinoid tumour
- Atypical Lung NET
- Autosomal dominant
- Avelumab (Bavencio)
- Avistan
- Axid (Nizatidine)
- Axilla
- Axillary nodes
- AZEDRA
B
- BAM
- Barium enema
- Barium swallow
- Barrett's Esophagus
- Bavencio
- Benign
- Benign NET
- Benign tumour
- Beta emitter
- Bevacizumab
- Bias
- Biased agonist
- Bile
- Bile acids
- Bile acid diarrhea
- Bile acid malabsorption
- Bile acid sequestrant
- Bile duct
- Bile salt
- Biliary
- Biliary tract cancer
- Bilirubin
- Bioavailable
- Biofeedback
- Biogenic amines
- Biological therapy
- Biomarker
- Biopsy
- Bland liver embolization
- Blinded study
- Blood area nitrogen (BUN)
- Blood brain barrier (BBB)
- Blood cells
- Blood clot
- Blood count
- Blood glucose
- Blood test
- Blood thinner
- Blue Book
- Blushing
- Bolus
- Bone marrow
- Bone marrow biopsy and aspiration
- Bone marrow suppression
- Bone metastases
- Bone scan
- Bowel
- Bowel cancer
- Bowel obstruction
- Bowel surgery
- Bradykinin
- Brain serotonin
- Brain tumour
- Breast cancer
- Breast NEN
- Broken capillaries
- Bronchi
- Bronchial
- Bronchial NET
- Bronchiole
- Bronchitis
- Bronchopulmonary Neuroendocrine Neoplasms (BP NEN)
- Bronchoscopy
- Bronchus
- BUN
- Butt dart
- Bynfezia Pen
- Bypass
- B12
- B3
C
- Cabometyx
- Cabozantinib
- Cachexia
- Calcitonin
- Calcitoninoma
- Calcitonin gene-related peptide (CGRP)
- Calcium
- Calorie
- CAM
- Camera pill
- Cancer
- Cancerous tumour
- Cancerversary
- Cancer anger
- Cancer causes
- Cancer grading
- Cancer of unknown primary (CUP)
- Cancer registries
- Cancer related fatigue
- Cancer research
- Cancer staging
- Cancer surveillance
- Cancer survivor
- Cancer vaccine
- Candidiasis
- Capecitabine
- CAPecitabine TEMozolomide (CAPTEM).
- Capecitabine (Xeloda)
- Capsule endoscopy
- CAPTEM
- Carbocaine
- Carbohydrate
- Carboplatin
- Carcinogen
- Carcinoid
- Carcinoid crisis
- Carcinoid heart disease
- Carcinoid rage
- Carcinoid syndrome
- Carcinoid tumour
- Carcinoma
- Cardiopulmonary hemodynamic instability
- Carney-Stratakis syndrome (CSS)
- CAR-T
- Catecholamines
- CA 19-9
- CA-125
- CA4P
- CB-839
- CDKN1B
- Cerebellum
- Chemotherapy
- Chemo bath
- Chinese dumplings
- Cholangiocarcinoma
- Cholecalciferol
- Cholecystectomy
- Cholestyramine
- Chromaffin cells
- Chromogranin
- Chromogranin A (CgA)
- Chromogranin B (CgB)
- Chromogranin C (CgC)
- Chronic condition
- Cimetidine
- Cisplatin
- Cisplatin/Etoposide
- CLARINET
- Clexane
- Clinical trial
- CLO test
- Cobalamin
- Coeliac disease
- Cognitive behavioural therapies (CBT)
- Colonoscopy
- Colony stimulating factor-1 receptor (CSF-1R)
- Colon cancer
- Colon NET
- Colorectal cancer
- Combined Neuroendocrine Carcinoma
- Combretastatin A-4 phosphate (CA4P)
- Cometriq
- Comorbidity
- COMPETE trial
- Complete blood count (CBC)
- Complex regional pain syndrome (CRPS)
- Constipation
- CONTROLNETS
- Core Biopsy
- Coronavirus
- Corticotrophin releasing hormone (CRH)
- Cortisol
- COR-003
- COR-005
- COVID-19
- Creon
- CRN00808
- CRN01941
- Crohn's Disease
- Cryoablation
- CT enterography
- CT guided aspiration
- CT scan
- Curative surgery
- Cure
- Cushing's disease
- Cushing's syndrome
- Cu-61
- Cyberchondria
- Cyberknife
- Cytoreductive
- Cytotoxic
- C cell
- C-peptide
- C‑Reactive Protein (CRP)
D
- DAXX
- Debulking surgery
- Degenerative bone disease
- Depression
- Dermal fibrosis
- Dermatitis
- Desmoplasia
- Detectnet
- DEXA scan
- Dexilent
- Dexlansoprazole
- Diabetes
- Diagnosis
- Diarrhea
- Diet
- Differential diagnosis
- Differentiation
- Diffuse hepatic steatosis
- Digestive enzymes
- DIPNECH
- Distal pancreatectomy
- Distant metastatis
- Distributive shock
- Diverticulitis
- DNA
- DNA methylation-based profiling
- Doctor Google (Dr. Google)
- Dopamine
- Dopamine receptors
- Dostarlimab
- DOTA-NOC
- DOTA-TATE
- DOTA-TOC
- Do no harm
- DP1038
- Dry skin
- DUNE trial
- Duodenal NET (dNET)
- Duodenum
- Durvalumab
- Dysbiosis
E
- Early Diagnosis
- ECG
- Echocardiogram
- Ectopic Cushing’s syndrome (ECS)
- Eczema
- Edotreotide
- EGFR
- EKG
- Electrolytes
- ELECT study
- Eliquis (apixaban)
- EMA
- Endocrine
- Endocrine function (pancreas)
- EndolucinBeta
- Endoscopic retrograde cholangiopancreatography (ERCP)
- Endoscopic ultrasound (EUS)
- Endoscopy
- ENETS
- Enterade® advanced oncology formula
- Enterochromaffin cells
- Enterolith
- Enucleation
- EPAS1
- Epidemiology
- Epidermal growth factor receptor (EGFR)
- Epinephrine
- Epi pens
- Erythematotelangiectatic rosacea (ETR)
- Erythrocyte sedimentation rate (ESR)
- Esomeprazole magnesium
- Essiac therapy (Essiac tea)
- Estrogen
- Ethanol
- Etoposide
- EUS
- Everolimus
- Exocrine cells
- Exocrine function (pancreas)
- Exocrine pancreatic insufficiency
- Explorer PET scan
- External beam radiotherapy
F
- False negative
- False positive
- Familial medullary thyroid cancer (FMTC)
- Familial NET
- Famotidine
- Fasting Gut Endocrine Profile
- Fatigue
- Fatty liver
- Fat malabsorption
- Fat soluble vitamins
- FCarboSt
- Fecal bile acid test
- Fecal elastase test
- Fecal fat
- FH
- Fibre
- Fibroblast growth factor receptor (FGFR)
- Fibrosis
- Fight or flight
- Fine needle aspiration (FNA)
- Flu
- Fluorine-18
- Fluoropyrimidine
- Fluorouracil (5-FU)
- Fluoro-18-L-Dihydroxyphenylalanine
- Flushing
- Focal fatty sparing
- FODMAP
- FOLFIRI
- FOLFOX
- Follicular cell
- Food allergy
- Food and Drug Administration
- Foregut
- Fosbretabulin tromethamine
- Fructose intolerance
- Full blood count (FBC)
- Full remission
- Functional tumour
G
- Gallbladder
- Gallium 68 (Ga68)
- Gamma camera
- Gamma knife
- Gastric NET
- Gastrin
- Gastrinoma
- Gastrin pH
- Gastroenterologist
- Gastroesophageal reflux disease (GERD)
- Gastrointestinal NET (GI-NET)
- Gastroscopy
- Gastro-entero-pancreatic neuroendocrine tumour (GEP-NET)
- Ga68 PET/CT
- Ga68-DOTANOC
- Ga68-DOTATATE
- Ga68-DOTATOC
- Ga68-DOTA-JR11
- Ga68-FAPI PET/CT
- Ga68-OPS202
- Generator (radionuclide)
- Generic drugs
- Genetics
- Genetic testing
- Genito-urinary NET
- Germline genetic mutations
- Gerson therapy
- GHRHoma
- Glioma
- Gliomablastoma
- GLP-1
- Glucagon
- Glucagonoma
- Glucose (cancer sugar myth)
- Glycated Hemoglobin (A1C)
- Goitre
- Gonadotropin-releasing hormone (GnRH)
- Grade
- Grading
- Granulinoma
- Graves’ disease
- Green tea
- Ground glass opacities
- Growth hormone (GH)
- Gut
- Gut Flora
- G protein-coupled receptors (GPCR)
H
- Haemangioblastoma
- Haemoglobin (hemoglobin)
- Hashimoto's disease
- HbA1c
- Head and Neck Cancer
- Heart disease
- Heat intolerance
- Hedinger syndrome
- Helicobacter pylori
- Hemangioma
- Hemoglobin
- Hepatic arterial embolization
- Hereditary cancer syndrome
- Hereditary pheochromocytoma/paraganglioma syndromes
- Heterogeneous
- High Grade NEC
- High grade neuroendocrine neoplasm (NEN)
- High grade neuroendocrine tumour (NET)
- High Residue Diet
- High-intensity focused ultrasound (HIFU)
- Hindgut
- HIPEC
- Histamine
- Histotripsy
- Hodgkin lymphoma
- Hormonal crisis
- Hormones
- Hormone therapy
- Hospice care
- Hotspot
- HPA axis
- Hurthle cell neoplasm
- Hydrocele
- Hydrocelectomy
- Hydrogen breath test
- Hydronephrosis
- Hyperadrenergic
- Hypercalcemia
- Hypercortisolism
- Hypergastrinemia
- Hyperglycemia
- Hyperhidrosis
- Hyperinsulinism
- Hyperparathyroidism
- Hypertension
- Hyperthermic intraperitoneal chemotherapy (HIPEC)
- Hyperthryroidism
- Hypervascularity
- Hypocortisolism
- Hypoglycemia
- Hypokalemia
- Hypotension
- Hypothalamus
- Hypothyroidism
- H2 blockers
- H2 receptor antagonist (H2RA)
I
- IBS
- IBS-C
- IBS-D
- IBS-M
- Ileocecal resection
- Ileum
- Immunotherapy
- Imodium
- Incidence
- Incidentaloma
- Incidental diagnosis
- Incomplete emptying
- Incurable cancer
- Indium 111-pentetreotide
- Inflammatory bowel disease (IBD)
- Inherited Cancer
- Insulin
- Insulinoma
- Insulin-like growth factor 1 (IGF-1)
- Interferon alpha (IFNα)
- Intermediate grade NET
- International Classification of Diseases for Oncology (ICD-O)
- International Classification of Diseases (ICD)
- Intestinal ischaemia
- Intraoperative chemotherapy
- Intraoperative hypertensive crisis
- Intraoperative radiotherapy (IORT)
- Invisible illness
- Iobenguane I 131
- Ipilimumab (Yervoy)
- Irinotecan (Campto)
- Iron Deficiency Anaemia
- Irreversible electroporation (IRE)
- Irritable bowel syndrome (IBS)
- Islet cell
- Islet of Langerhams
L
- Lactose intolerance
- Lactulose
- Laetrile (amygdalin or vitamin B17)
- Lanreotide
- Lansoprazole
- Laparoscopic surgery
- Large cell neuroendocrine carcinoma (LCNEC)
- Larotrectinib sulfate
- Late Diagnosis
- Lenvatinib (Lenvima)
- Lenvima
- Leukaemia (US Leukemia)
- Levoketoconazole (Recorlev)
- Levothyroxine
- Lipase
- Liquid biopsy
- Liver
- Liver cyst
- Liver directed therapy
- Liver embolization
- Liver lesion
- Liver metastases
- Loperamide hydrochloride
- Low Grade NETs
- Low residue diet
- lung
- Lung Cancer
- Lung NETs
- Lung nodules
- Lutathera
- Luteinizing hormone (LH)
- LUTIA clinical trial
- Lu 177 dotatate
- Lu-177
- Lymphadenectomy
- Lymphatic system
- Lymphedema
- Lymphoma
- Lymph nodes
- Lynch syndrome
M
- Magnetic resonance imaging (MRI) scan
- Malabsorption
- Malignant
- Mammalian Target of Rapamycin (mTOR)
- Mammalian target of rapamycin (mTOR) inhibitor
- Mammogram
- MANEC
- Marcaine
- Mastocytosis
- Mast cell
- MDH2
- Medical food
- Medicines and Healthcare Products Regulatory Agency
- Medicines and Healthcare products Regulatory Agency (MHRA)
- Medullary thyroid cancer (MTC)
- Melanoma
- Melatonin
- Meningioma
- Menopause
- MENX
- MEN1 syndrome
- MEN2A syndrome
- MEN2B syndrome
- MEN2 syndrome
- MEN4 syndrome
- Merkel cell carcinoma
- Mesenteric Fibrosis
- Mesenteric root
- Mesentery
- Metanephrines
- Metasasis
- Metastatic Neuroendocrine Cancer
- Metronidazole
- MIBG scan
- Microsatellite instability-high (MSI-H)
- Midgut
- Mineral
- Misdiagnosis
- Mitotic count
- Mitotic rate
- Mixed Neuroendocrine Non-Neuroendocrine Neoplasms (MiNEN)
- Molecular markers
- Monoamine oxidase inhibitors (MAOIs)
- Monoclonal antibodies
- MTD201
- mTOR inhibitor
- Multidisciplinary team (MDT)
- Multikinase inhibitor
- Multimodal treatment
- Multiple Endocrine Neoplasia (MEN)
- Multiple myeloma
- Multi tyrosine kinase inhibitors (TKIs)
- Mushrooms
- MYCAPSSA
- Myeloma
N
- NanoKnife®
- Naproxen
- National Cancer Institute
- National Institutes of Health
- National Institute for Health and Care Excellence (NICE)
- Nausea
- Neoplasm
- Netazepide
- NETDetect
- NETest
- NETSPOT
- NETTER-1
- NETTER-2
- NET Cancer Day
- NET Centre of Excellence
- NET syndromes
- Neuroblastoma
- Neuroendocrine
- Neuroendocrine cancer
- Neuroendocrine carcinoma (NEC)
- Neuroendocrine neoplasm (NEN)
- Neuroendocrine tumour (NET)
- Neurofibromatosis type 1 (NF1)
- Neurokinin A (NKA)
- Neurologic paraneoplastic syndromes
- Neuropeptide K
- Neurotensin
- Neurotransmitter
- Nexium
- NF1
- NHS
- Niacin
- Night sweat
- Nivolumab (Opdivo)
- Nizatidine
- NKA
- Nodule
- Noid
- Non-functional tumour
- Non-small cell lung cancer (NSCLC)
- Noradrenaline
- Norepinephrine
- North American Neuroendocrine Tumor Society (NANETS)
- Novocaine
- No evidence of disease (NED)
- No-Carrier-Added Lutetium-177 (n.c.a. Lu177)
- NT-proBNP
- Nuclear medicine
- Nutrition
- Nutrizym
O
- Octreoscan (Octreotide scan)
- Octreotide
- Octreotide scan
- Octreotide soak
- Octreotide (Octreotide acetate)
- Octreotide-RP
- Octreo-ratiopharm®
- Ocular Rosacea
- Olaparib
- Olatuton®
- Omega 3
- Omeprazole
- Omeprazole and sodium bicarbonate
- Oncologist
- Oncolytic virus
- ONC201
- Ondansetron (Zofron)
- Opdivo (Nivolumab)
- Osteoblastic activity
- Osteoporosis
- Ovarian cancer
- Ovarian NEN
- Overactive thyroid
- Overdiagnosis
- Oxaliplatin (Eloxatin)
- Oxitriptan
- Oxytocin
P
- Paclitaxel (Taxol)
- Palliative care
- Palliative treatment
- Palpitation
- panc
- Pancreas
- Pancrease
- Pancreastatin
- Pancreatic adenocarcinoma
- Pancreatic cancer
- Pancreatic cyst
- Pancreatic enzyme replacement therapy (PERT)
- Pancreatic insufficiency
- Pancreatic NET (PanNET)
- Pancreatic polypeptide (PP)
- Pancreatic pseudocyst
- Pancreatic uncinate process
- Pancreatin
- Pancreatogenic diabetes
- Pancreoprivic diabetes
- Pancrex
- Pantoloc control
- Pantoprazole
- Papillary thyroid cancer
- Papulopustular (acne) rosacea
- Paraganglia
- Paraganglioma
- Paraneoplastic syndromes
- Parathyroid gland
- Parathyroid hormone (PTH)
- Parathyroid NET
- Parotid gland NET
- PARP Inhibitor
- Partial remission
- Pasireotide
- Patent foramen ovale (PFO)
- Pathology
- PDR001
- PD-1/PD-L1 Inhibitors
- Pellagra
- Pembrolizumab (Keytruda)
- Pemetrexed disodium
- Pentetreotide
- PEN-221
- Pepcid (Famotidine)
- Peptide
- Peptide receptor radionuclide therapy (PRRT)
- Peripheral Serotonin
- Peritoneal carcinomatosis
- Pernicious anaemia
- PET Scan
- Pheochromocytoma
- Physician
- Physiological uptake
- Pituitary gland
- Pituitary NET (PitNET)
- PI3K inhibitor
- Plasma 5HIAA
- Platelet-derived growth factor receptor (PDGFR)
- Pleural Fibrosis
- pNET
- Poorly differentiated
- Post operative seroma
- PPoma
- PRCRT
- Prediabetes
- Pressor amines
- Prevacid (Lansoprazole)
- Prevalence
- Pre-existing condition
- Prilosec (Omeprazole)
- Probiotic
- Procaspase-activating compound-1 (PAC-1)
- Prognosis
- Progressive cancer
- Proinsulin
- Proliferative rate
- Prostaglandin
- Prostate Cancer
- Protease
- Proteasome inhibitors
- Protein kinase inhibitor
- Protonix (Pantoprazole)
- Proton beam therapy
- Proton pump inhibitors (PPI)
- PRRT
- Pruritus
- Pseudomyxoma peritonei (PMP)
- PTHrPoma
- Pulmonary embolism
- Pulmonary fibrosis
- Pustule
- PV-10
R
- Rabeprazole (Aciphex)
- RADIANT
- Radiation therapy
- Radioactive iodine
- Radioembolization
- Radioimmunotherapy
- Radiolabelled somatostatin analogue
- Radioligand
- Radioligand therapy
- Radionuclide
- Radiopeptide
- Radiotherapy
- Radio Frequency Ablation (RFA)
- Ranitidine (Zantac)
- Rash
- RB1
- RECORLEV (levoketoconazole)
- Rectal cancer
- Rectal NET
- Red blood count (RBC)
- Remission
- Renal cell carcinoma (RCC)
- Renal insufficiency
- Residue (food)
- RET
- Retroperitoneal Fibrosis
- Retroperitoneum
- Rhinophyma
- Right hemicolectomy
- Rosacea
- Rose Bengal
S
- Sandostatin
- Sapanisertib
- SARTATE™
- Satoreotide (Lutetium-177)
- SB NET
- Scan
- Scanxiety
- SCF node
- Scleroderma
- SDHA
- SDHAF2
- SDHAF2(SDH5)
- SDHB
- SDHC
- SDHD
- Secretogranin II
- SEER
- Selective Internal Radiotherapy (SIRT)
- Selective Serotonin Reuptake Inhibitor (SSRI)
- Semaglutide
- Serotonin
- Serotonin and norepinephrine reuptake inhibitor (SNRI)
- Serotonin syndrome
- Serum ferritin
- Serum serotonin
- Serum 7αC4 test
- Setrons
- Side effect
- Siegfried Oberndorfer
- Sigmoidoscopy
- SIGNIFOR® (Pasireotide)
- SI NET
- Skin NET
- Sleep hyperhidrosis
- Small cell lung cancer (SCLC)
- Small cell neuroendocrine carcinoma (SCNEC)
- Small intestine bacterial overgrowth (SIBO)
- Small intestine NET (SI NET)
- Solid tumour
- Solucin ®
- SomaKit TOC
- Somatoprim
- Somatostatin
- Somatostatinoma
- Somatostatin analogues
- Somatostatin receptors (SSTR)
- Somatostatin receptor scintigraphy (SRS)
- Somatuline Autogel (US: depot)
- SOM230
- Spartalizumab
- special
- SPECT
- Spider Veins
- SPINET
- Splenosis
- Splenunculus
- Squamous cell carcinoma
- SSTR-PET
- Stable cancer
- Stage
- Standardised uptake value (SUV)
- Steatorrhea
- Stem Cell
- Stereotactic body radiotherapy (SBRT)
- Stereotactic radiosurgery (SRS)
- Sternoclavicular joint
- Stomach cancer
- Stomach cramp
- Stomach ulcer
- Streptozotocin (Zanosar)
- Stress
- St. John's wort
- Subpectoral lymph node
- Substance K
- Substance P
- Succinate Dehydrogenase Subunit Genes (SDHx)
- Sulfatinib
- Sunitinib (Sutent)
- Superior mesenteric artery
- Superior mesenteric vein
- Supplements
- Supraclavicularfossa
- Supraclavicularfossa (SCF) lymph nodes
- Surgeon
- Surgery
- Surufatinib
- SurVaxM
- Surveillance
- Survivin
- Survivor
- Survivorship
- Sweating
- Sweet's syndrome
- Symptom
- Syndrome
- Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
T
- Tachycardia
- Tachykinin
- Tagamet
- Talazoparib
- Targeted alpha-emitter therapy (TAT)
- Targeted therapy
- TAS-102
- Tecentriq (Atezolizumab)
- Technetium-99m (Tc-99m)
- Telangiectasia
- Telotristat ethyl (Xermelo)
- Temozolomide (Temodal)
- Teratoma
- Terbium-161 (161Tb-DOTA-LM3)
- Terminal cancer
- Terminal ileum
- Testicular cancer
- Testosterone
- Tetracycline
- Theranostics
- The 5 E's
- Thorson-Bioerck syndrome
- Thymic NEN
- Thyroid
- Thyroiditis
- Thyroid cancer
- Thyroid NET
- Thyroid nodule
- Thyroid stimulating hormone (TSH)
- Thyroxine (T4)
- Tidutamab
- TNM staging system
- TOCscan®
- Total gastrectomy
- Total pancreatectomy
- TPH1
- TPH2
- TP53
- TraceNET
- Transarterial chemo embolization (TACE)
- Transarterial embolizaton (TAE)
- Transarterial radioembolization (TARE)
- Travel with Ronny
- Triapine
- Tricyclic antidepressant
- Triglycerides
- Triiodothyronine (T3)
- Tryptophan
- Tryptophan hydroxylase (TPH)
- Tuberous sclerosis (TSC)
- Tumor board
- Tumour marker
- Tumour mutational burden (TMB)
- Tumour (Tumor)
- Type 1 diabetes
- Type 2 diabetes
- Type 3c diabetes
- Type 3c diabetes mellitus (T3cDM)
- Typical lung NET
- Tyramine
- Tyrosine kinase inhibitor (TKI)
V
- Vaccine
- Vanillylmandelic acid (VMA)
- Vascular
- Vascular disrupting agent (VDA)
- Vascular endothelial growth factor (VEGF)
- Vasoactive amines
- Vasoactive intestinal peptide (VIP)
- Vasoactive peptides
- Vasodilation
- Vasosuppressors
- Vepesid)
- Verner-Morrison syndrome
- Vertebral haemangioma
- Vimovo
- VIPoma
- Vitamin A
- Vitamin ADEK
- Vitamin B complex
- Vitamin B1
- Vitamin B12
- Vitamin B2
- Vitamin B3
- Vitamin B5
- Vitamin B6
- Vitamin B7
- Vitamin B9
- Vitamin C
- Vitamin D
- Vitamin E
- Vitamin K
- VMT-𝛼-NET
- Von Hippel-Lindau (VHL) Syndrome
- Von Recklinghausen's disease
W
#
- 111In-DTPA-D-Phe1
- 123I-Metaiodobenzylguanidine (mIBG)
- 131I-Metaiodobenzylguanidine (mIBG)
- 177Lu OPS 201
- 177Lu-DOTA-EB-TATE
- 177Lu-DOTA-LM3
- 177Lu-Edotreotide (Solucin®)
- 177Lu-PSMA-R2
- 18F-FDG
- 18F-FDG PET/CT
- 18F-FDOPA
- 212Pb
- 212Pb-AR-RMX
- 212Pb-AR-RMX
- 225Ac
- 24-hour urinary catacholamines and metanephrines
- 3D conformal radiation therapy
- 5-Fluorouracil (5-FU)
- 5-HIAA
- 5-HT
- 5-HTP
- 5-HT3
- 5-HT3-RA
- 5-Hydrotryptophan (5-HTP)
- 5-Hydroxyindoleacetic Acid (5-HIAA)
- 5-Hydroxytryptamine (5-HT)
- 64Cu-DOTATATE
- 64Cu-SARTATE
- 67Cu-SARTATE
- 68Ga edotreotide (TOCscan®)
- 68Ga-PSMA-R2
- 75Se-homocholic acid taurine (75SeHCAT)
Disclaimer
I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me.
Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional.
Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.
Top 10 Posts & Pages in the last 48 hours (auto updates) (Click the titles to read them)
Thanks for reading.
Personal Facebook. Like this page please.
Blog Facebook. Like this page please.
Awareness Facebook Like this page please.
Sign up for my newsletters – Click Here
My Diagnosis and Treatment History
Check out my online presentations
Check out my WEGO Health Awards
Check out my Glossary of Terms – click here
Please Share this post for Neuroendocrine Cancer awareness and to help another patient
Things are not always how they seem
Graphic courtesy of SoBadAss.me (Sam Cleasby) In 2014, Chris and I walked 84 miles along Hadrian’s Wall on the English/Scottish border. It was a fantastic
Neuroendocrine Cancer Online Forums: frighteningly good or good at frightening?
OPINION When I was diagnosed, I was happy with my own research and kept away from forums on the advice of a fellow patient who
Colonoscopy Comedy
Last year I wrote a series of articles on the ‘coping’ side of cancer, one of which was about still being able to have a
Surgery – the gift that keeps on giving
I first wrote this article in December 2014. My thoughts went back to my first surgery in 2010 when I was discharged 4 weeks before
Piss off cancer, it’s 13 years since my liver surgery!
I’m still here I was 54 years and 9 months old at diagnosis on 26th July 2010. For the first few months, I had no
Chocolate – the NET effect
I’ve always had a ‘sweet tooth’ and the softer the sweet the better – toffee, marshmallows, chocolate, jelly babies, jelly beans, fruit pastilles, fudge, liquorice
A Phase 2 Open Label Study to Evaluate the Safety and Effectiveness of 212Pb-DOTAMTATE (alpha-emitter) in Subjects With Somatostatin Receptor Positive NETs
Update 12th January 2024 FDA Grants Breakthrough Therapy Designation to AlphaMedix for Gastroenteropancreatic Neuroendocrine Tumors (Lung and other Non-GEPNETs – see author’s comments below)
A Review of March 2024 on RonnyAllan.NET
I’m thankful to the loyal supporters on my blog site and the other social media sites day and night (and I do note some doing
From Whipple to Waikiki by Jerry Chezick. Surf’s up!
An essay by Jerry CrezickJerry is a Pancreatic Neuroendocrine Tumor (NET) patient recovering after a Whipple operation carreid out early 2022. He soon realised he
Subscribe to Blog via Email
A cup of tea
I would also mention those who contributed to my “Tea Fund” which resides on PayPal. You don’t need a PayPal account as you can select a card but don’t forget to select the number of units first (i.e. 1 = £4, 2 = £8, 3 = £12, and so on), plus further on, tick a button to NOT create a PayPal account if you don’t need one. Clearly, if you have a PayPal account, the process is much simpler
Through your generosity, I am able to keep my sites running and provide various services for you. I have some ideas for 2023 but they are not detailed enough to make announcements yet.
This screenshot is from every single post on my website and depending on which machine you are using, it will either be top right of the post or at the bottom (my posts are often long, so scroll down!)
Related
Discover more from Ronny Allan - Living with Neuroendocrine Cancer
Subscribe to get the latest posts to your email.
Ronny
I know that you have a lot information about this cancer, I have metastasis in the liver. I have every 28 days somatuline depot and chemoembolization when I need it. When I start to feel sick because new tumors I have pain in my joins like electric shocks. My doctor said that doesn’t have nothing to do with cancer. After the chemoembolization the pain go away so I suspect that is related. Please I want to have your opinion
Lolita Fernandez
I can’t really say yes or no to your question, I am not a doctor. It could be side effects of your treatment but that is a guess. Doctors normally say to allow 3 or 4 monthly injections to let your body get used to it.